Skip to content
Home/Companies/Biotech/PRIMACYT Cell Culture Technology GmbH
PRIMACYT Cell Culture Technology GmbH

PRIMACYT Cell Culture Technology GmbH

Biotech·Germany·Active·22yr hold
Entry
2004
Hold
22yr
Status
Active

Who owns PRIMACYT Cell Culture Technology GmbH?

PRIMACYT Cell Culture Technology GmbH is currently owned by GENIUS Venture Capital through Technologiefonds Mecklenburg-Vorpommern (2004 vintage), since 2004.

Hand-verified · updated 2026-08-10

GENIUS Venture Capital
Investor
GENIUS Venture Capital
Technologiefonds Mecklenburg-Vorpommern · 2004 · VC

Key facts

HQGermany
SectorBiotech
StatusActive
Websiteprimacyt.com

More from Technologiefonds Mecklenburg-Vorpommern

Other portfolio companies in the same fund.

RoweMed AG
Exited 2023
MedTechGermany· 2015
E-PATROL north GmbH
Exited 2019
HR TechGermany· 2012
to
new enerday GmbH
Exited 2014
ClimateTechGermany· 2011
to
AIRSENSE Analytics GmbH
Active
Deep TechGermany· 2005

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track PRIMACYT Cell Culture Technology GmbH

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on PRIMACYT Cell Culture Technology GmbH.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue